Immune Biosolutions inc.
$490,750.00 CAD
≈ 6 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2022-2023
- Agreement period
- August 5, 2022 – January 31, 2024
- Reference
- nrc-cnrc:172-2022-2023-Q2-993841
Published purpose
The main objective of the project is to develop at least one bispecific or multispecific therapeutic antibody in pulmonary immuno-oncology. To this end, the company will improve its platform to accelerate the therapeutic antibody discovery process through the implementation of new technologies, automation and high throughput processing of the experimental data collected. This platform will be able to efficiently generate multispecific antibodies with demonstrated therapeutic efficacy.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions